Fundraising Fox
/Companies
Sign in

Biocytogen

Beijing, CN · 5 known investors

Find your way into Biocytogen

Sign up to see every warm intro you have to Biocytogen

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Biocytogen team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.

BiotechDeep TechHealthtech

Founders & leadership

YSYuelei Shen
Yuelei ShenFounder · CEOYuelei Shen founded Biocytogen in 2008 in the United States, establishing its China operations in Beijing in 2009. Shen has expertise in immunology, autoimmune disease research, mouse gene targeting, infectious disease research, and antibody drug development.

Investors · 5

3E Bioventures CapitalreportedPalo Alto

How we know: avcj.com · Not right? Tell us

Oriza HoldingsreportedSuzhou

How we know: avcj.com · Not right? Tell us

SDIC Venture CapitalreportedBeijing

How we know: funding news · avcj.com · Not right? Tell us

Also in the syndicate · 1

CMB International Capitallead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 1

Taconic BiosciencesTaconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services. It serves drug discovery and preclinical researchers, offering integrated laboratory animal models and services from model selection through study-ready cohorts.

Companies working in the same space as Biocytogen.

Frequently asked questions

What does Biocytogen do?
Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.
Who founded Biocytogen?
Biocytogen was founded by Yuelei Shen.
Who are Biocytogen's investors?
Biocytogen's investors include Cowin Capital Group, 3E Bioventures Capital, Oriza Holdings, SDIC Venture Capital.
Where is Biocytogen headquartered?
Biocytogen is headquartered in Beijing, CN.